BridgeBio Pharma (BBIO) Insider Trading & Ownership → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free BBIO Stock Alerts $27.70 -0.09 (-0.32%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.52%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$60.17 M Get BBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BBIO Insider Buying and Selling by Quarter Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE BridgeBio Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/1/2024Randal W ScottDirectorSell2,500$34.00$85,000.00 1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.55 12/26/2023Frank MccormickDirectorSell100,000$42.06$4,206,000.00 12/18/2023Randal W ScottDirectorSell2,000$40.00$80,000.00 8/17/2023Brian C StephensonCFOSell22,683$28.59$648,506.97 8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.68 7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.00 5/17/2023Brian C StephensonCFOSell24,424$14.01$342,180.24 5/17/2023Neil KumarCEOSell51,552$14.01$722,243.52 (Data available from 1/1/2013 forward) BBIO Insider Trading Activity - Frequently Asked Questions Who is on BridgeBio Pharma's Insider Roster? The list of insiders at BridgeBio Pharma includes Brian C Stephenson, Douglas A Dachille, Frank Mccormick, Global Investors Lp Viking, Hannah Valantine, Neil Kumar, Randal W Scott, Richard H Scheller, and Ronald J Daniels. Learn more on insiders at BBIO. What percentage of BridgeBio Pharma stock is owned by insiders? 28.52% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings. Which BridgeBio Pharma insiders have been selling company stock? The following insiders have sold BBIO shares in the last 24 months: Brian C Stephenson ($4,085,472.83), Frank Mccormick ($4,206,000.00), Global Investors Lp Viking ($52,500,000.00), Hannah Valantine ($110,682.55), Neil Kumar ($8,502,665.80), and Randal W Scott ($165,000.00). How much insider selling is happening at BridgeBio Pharma? Insiders have sold a total of 2,594,731 BridgeBio Pharma shares in the last 24 months for a total of $69,569,821.18 sold. More Insider Trading Tools from MarketBeat Related Companies: Organon & Co. Insider Selling Perrigo Insider Selling Nuvalent Insider Selling Apellis Pharmaceuticals Insider Selling Alpine Immune Sciences Insider Selling Alkermes Insider Selling Madrigal Pharmaceuticals Insider Selling Blueprint Medicines Insider Selling CymaBay Therapeutics Insider Selling Insmed Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:BBIO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
